#Japan #Tokyo #Alfresa #12 Pharmacy #Animo

Partnership Towards a New Era of Animal Healthcare

Alfresa Co., Ltd., along with its subsidiary, has entered into a significant agreement with 12 Pharmacy Co., Ltd. and animo Co., Ltd. aimed at revolutionizing animal healthcare. As the importance of pets in families increases, the demand for quality veterinary services has surged. The collaboration focuses on establishing a next-generation animal healthcare platform to provide essential services and support for pet owners and veterinarians alike.

Background and Objectives

The increasing familial trend and longevity of pets have heightened awareness regarding their health. Pet owners are now seeking ongoing healthcare management and medical service access for their beloved animals. Amidst these evolving demands, veterinary clinics are pressured to manage not only medical consultations but also various operational aspects such as inventory control, prescription management, and communication with pet owners.

In response, the Alfresa Group is set on expanding and transforming its business portfolio through its long-term vision aimed at growth by 2032. This entails exploring new business opportunities in the fields of animal medical digital transformation (DX), solutions for veterinarians and pet owners, and innovations within the animal healthcare supply chain.

The recent agreement signifies a pivotal step for the three companies, establishing a distance-driven connection between veterinary clinics and pet owners. The collaboration will incorporate 12 Pharmacy's online prescription system and delivery services alongside animo's veterinary and pet owner platform and health data infrastructure. This synergy is envisioned to enhance efficiency in veterinary operations while elevating the convenience of services available to pet owners, thus setting the stage for the advent of fresh services within the animal healthcare sector.

Detailed Aspects of the Agreement

The associated companies will engage in detailed discussions surrounding a few key elements:
1. Development of systems enabling prescription services for veterinarians and pet owners via the online prescription platform.
2. Establishment of a cohesive information-sharing framework through the developed system.
3. Project planning and service development within the realm of animal healthcare.

This collaboration signifies a concerted effort to leverage the specialized expertise of each company. 12 Pharmacy will utilize its operational knowledge derived from specialized prescription services directed at animal hospitals and its established online prescription system. On the flip side, animo will lend its infrastructure development, real-world data analytics concerning veterinary medicine, and service planning to the endeavor. Lastly, Alfresa will contribute its insights into enhancing operational efficiency for healthcare institutions and the pharmaceutical distribution system, hence facilitating the consolidation of business planning and service development.

Corporate Overview

Here’s a brief insight into the partners involved:

12 Pharmacy Co., Ltd.

Founded in Tokyo, the company has specialized in animal pharmacy services, evolving alongside the pet care industry.

animo Co., Ltd.

Located in Hokuto City, Yamanashi Prefecture, animo is recognized for its innovative approaches to animal healthcare, focusing on data and technological integration in veterinary services.

Timeline

The agreement was formalized on August 25, 2026.

Future Outlook

Although this agreement is expected to have minor immediate impacts on current fiscal results, it is projected to substantially enhance the corporate value of the affiliated groups in the long run. The companies are committed to providing updates regarding any forthcoming disclosures related to this venture, underscoring their dedication to transparency and progress in the evolving landscape of animal healthcare.